Alt5 Sigma Corp Surges in Q1 2025 Amid Market Volatility with Strong Performance in Specialty Retail Health Care
Alt5 Sigma Corp reported a strong Q1 2025 performance, with a market capitalization of $90.4 million and a promising future outlook driven by its focus on non-addictive pain-relieving drugs.
2 minutes to read